Armata Pharmaceuticals (ARMP) Treasury Shares (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Treasury Shares of $135000.0 for Q1 2026, down 33.33% on a YoY basis from $202500.0 in Q1 2025, and down 11.48% sequentially from $152500.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Treasury Shares (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 13 years of Treasury Shares data on file, last reported at $135000.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares fell 33.33% year-over-year to $135000.0; the trailing twelve-month figure through Mar 2026 stood at $135000.0 (down 33.33% YoY), and the FY2025 full-year result was $152500.0, down 30.68% from the prior year.
- Treasury Shares declined to $135000.0 in Q1 2026, from $152500.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $290000.0 in Q1 2024 to a low of $9748.0 in Q3 2022.
- A 5-year average of $158948.1 and a median of $152500.0 in 2025 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares sank 93.67% in 2022 and soared 2874.97% in 2024, its largest moves.
- Tracing ARMP's Treasury Shares over 5 years: stood at $129666.0 in 2022, then soared by 54.24% to $200000.0 in 2023, then rose by 10.0% to $220000.0 in 2024, then slumped by 30.68% to $152500.0 in 2025, then slipped by 11.48% to $135000.0 in 2026.
- Business Quant data shows ARMP's Treasury Shares at $135000.0 in Q1 2026, $152500.0 in Q4 2025, and $152500.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | 135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 152,500.00 |
| Dec 31, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Dec 31, 2024 | 220,000.00 |
| Dec 31, 2024 | 220,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |